Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds

NARecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Diabetic Foot UlcerVenous Leg Ulcer
Interventions
DEVICE

EPIFIX

EPIFIX® is an allograft derived from dehydrated human amnion/chorion membrane. EPIFIX is a medical device in Japan (Generic name: Material using human amniotic membrane for promotion of tissue healing) for use on intractable ulcers that are non-responsive to existing therapies for the purpose of promoting wound healing.

Trial Locations (5)

650-0017

RECRUITING

Kobe University Hospital, Kobe

350-0495

RECRUITING

Saitame Medical University Hospital, Iruma-gun

113-8431

RECRUITING

Juntendo University Hospital, Bunkyō-Ku

181-8611

RECRUITING

Kyorin University Hospital, Mitaka-shi

160-0023

RECRUITING

Tokyo Medical University Hospital, Shinjuku-Ku

All Listed Sponsors
collaborator

CMIC Co, Ltd. Japan

INDUSTRY

lead

MiMedx Group, Inc.

INDUSTRY